Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MRI-guided immunotherapy development for multiple sclerosis in a primate.

Bert A 't Hart1, Paul Smith, Sandra Amor

  • 1Department of Immunobiology, Biomedical Primate Research Centre, Rijswijk, The Netherlands. hart@bprc.nl

Drug Discovery Today
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apical hypercontractility mitigates impaired diastolic filling and lower intraventricular haemodynamic forces in human bed rest.

Experimental physiology·2026
Same author

Induction of subtle blood-brain barrier dysfunction using preclinical diagnostic ultrasound combined with microbubbles.

Fluids and barriers of the CNS·2026
Same author

Computed Tomography and Magnetic Resonance Imaging.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

Species-specific effects of positive end-expiratory pressure on diaphragm and chest wall geometry in mice, rats, and humans.

American journal of physiology. Regulatory, integrative and comparative physiology·2026
Same author

Deep Learning Reconstruction Enables Diagnostic-Quality 0.4T Knee and Spine MRI in One-Third of the Time.

NMR in biomedicine·2026
Same author

Longitudinal 3D-DCE MRI Assessment of Placental Perfusion Under Reduced Uterine Perfusion Pressure in Pregnant Rats.

NMR in biomedicine·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
See all related articles

New preclinical models in non-human primates may help bridge the gap between animal studies and human patients for multiple sclerosis (MS) therapies. This advance could improve the translation of promising treatments for this serious neurological disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Primate Models

Background:

  • Multiple sclerosis (MS) is a significant neurological disorder affecting young adults in Europe and the USA.
  • Current therapeutic development for MS faces challenges due to the poor translation of preclinical findings from animal models to human patients.
  • Existing animal models often fail to accurately predict treatment efficacy in humans.

Purpose of the Study:

  • To introduce and describe a novel preclinical model for multiple sclerosis (MS) research.
  • To address the critical need for improved models that better predict human therapeutic responses.
  • To facilitate the advancement of effective treatments for multiple sclerosis.

Main Methods:

  • Utilizes a non-human primate model for studying multiple sclerosis.

Related Experiment Videos

  • Focuses on preclinical evaluation of potential therapeutic strategies.
  • Aims to enhance the translational validity of research findings.

    • Main Results:

    • Presents a new non-human primate model for multiple sclerosis.
    • Highlights the potential of this model to overcome limitations of current animal models.
    • Suggests improved prediction of treatment outcomes in patients.

    Conclusions:

    • The described non-human primate model offers a promising avenue for multiple sclerosis research.
    • This model may enhance the successful development of therapies by bridging the preclinical-clinical gap.
    • Further research using this model could accelerate the discovery of effective multiple sclerosis treatments.